Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 39 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Health Economics Privak II from Nazareth-De Pinte, company number BE0685563039, closed financial year 2025 with a result of € -6.9 million after tax. Compared with financial year 2024, the result moved from € -1.2 million to € -6.9 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 34.9 million
▼ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -6.9 million
▼ 457 % more loss than in 2024
Profit after tax over the fiscal year.
€ 614,292
▲ 183% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -6.7 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,442
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 22 days on average.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Profit after taxes | € 1,108,663 | € 1,831,980 | € -1,242,754 | € -6,920,667 | ▼ € 5.7 million |
| Equity | € 33,229,268 | € 49,513,072 | € 37,691,625 | € 34,878,344 | ▼ 7% |
| Total debts | € 6,689,602 | € 97,330 | € 476,637 | € 1,808,112 | ▲ 279% |
| Cash | € 5,293,386 | € 84,906 | € 217,180 | € 614,292 | ▲ 183% |
| Retained profit | € 1,976,773 | € 1,984,482 | € 231,092 | € -6,689,575 | ▼ € 6.9 million |
| Dividend | € 768,727 | € 1,824,272 | € 510,636 | € 0 | ▼ 100% |
| Balance sheet total | € 39,918,870 | € 49,610,402 | € 38,168,262 | € 36,686,456 | ▼ 4% |
Key figures of Health Economics Privak II, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Health Economics Privak II?
What happened at Health Economics Privak II in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 6.9 million. Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 1.1 million profit in 2022 to € 6.9 million loss in 2025.
Best year ever: 2023, with € 1.8 million profit.
Paid out € 3.1 million in dividends to the owners in total.
Pays suppliers within 22 days on average.
A new publication or filing at Health Economics Privak II? We notify you, reason included.
Follow Health Economics Privak IIDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Health Economics Privak II are Anne Frida Magdalene Portwich, Fouad Oscar Azzam and Rudy Dekeyser. The shares are held by Participatiemaatschappij Vlaanderen NV (14.4%) and BNP Paribas Fortis Private Equity Belgium NV (14.4%). It owns 100% of Health Economics Belgium II itself.
Directors
According to the 2025 annual accounts
Anne Frida Magdalene Portwich
Director
Fouad Oscar Azzam
Director
Rudy Dekeyser
Managing director
Also active at: reMYND, ANTIKANKERFONDS-FONDS ANTICANCER-ANTICANCER FUND, R.A.D. LIFE SCIENCES, LSP 6 Privak, LSP 7 Privak, EQT Partners Belgium, Fondation Fournier Majoie pour l'Innovation, EQT Health Economics 3 Privak +1 more
Shareholders
Participations
Establishments
Establishment units
Physical locations of this company
Klein Nazareth 12
9840 Nazareth-De Pinte
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →R.A.D. LIFE SCIENCES same network
€ 7,189 gross margin · 2025
SysteemUnoDue
LSP 6 Privak same network
LSP 7 Privak same network
EQT Health Economics 3 Privak same network
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0685.563.039
- VAT number
- BE 0685.563.039
- Registered office
- Klein Nazareth 12, 9840 Nazareth-De Pinte
- Names & denominations
- Health Economics Privak II
- Enterprise type
- Rechtspersoon
- Legal form
- Limited partnership
- Legal situation
- Normale toestand
- Start date
- 1 December 2017
- Peppol
- Not registered